- Home
- BMRN vs UNM Comparison
BMRN vs UNM Comparison
Compare BMRN & UNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- UNM
- Stock Information
- Founded
- BMRN 1996
- UNM 1848
- Country
- BMRN United States
- UNM United States
- Employees
- BMRN N/A
- UNM N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- UNM Accident &Health Insurance
- Sector
- BMRN Health Care
- UNM Finance
- Exchange
- BMRN Nasdaq
- UNM Nasdaq
- Market Cap
- BMRN 12.1B
- UNM 12.5B
- IPO Year
- BMRN 1999
- UNM 1986
- Fundamental
- Price
- BMRN $59.82
- UNM $80.27
- Analyst Decision
- BMRN Buy
- UNM Buy
- Analyst Count
- BMRN 22
- UNM 13
- Target Price
- BMRN $93.43
- UNM $86.92
- AVG Volume (30 Days)
- BMRN 1.6M
- UNM 1.4M
- Earning Date
- BMRN 05-01-2025
- UNM 04-29-2025
- Dividend Yield
- BMRN N/A
- UNM 2.08%
- EPS Growth
- BMRN 152.82
- UNM 26.80
- EPS
- BMRN 2.71
- UNM 8.54
- Revenue
- BMRN $2,950,227,000.00
- UNM $12,778,600,000.00
- Revenue This Year
- BMRN $12.27
- UNM $5.06
- Revenue Next Year
- BMRN $9.86
- UNM $3.74
- P/E Ratio
- BMRN $22.11
- UNM $9.45
- Revenue Growth
- BMRN 19.36
- UNM 1.82
- 52 Week Low
- BMRN $52.93
- UNM $48.38
- 52 Week High
- BMRN $94.85
- UNM $84.48
- Technical
- Relative Strength Index (RSI)
- BMRN 40.34
- UNM 55.97
- Support Level
- BMRN $60.92
- UNM $73.17
- Resistance Level
- BMRN $65.40
- UNM $79.94
- Average True Range (ATR)
- BMRN 1.96
- UNM 1.94
- MACD
- BMRN 0.06
- UNM 0.37
- Stochastic Oscillator
- BMRN 21.52
- UNM 83.68
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.